These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12691308)

  • 1. Monoclonal antibodies in the treatment of ovarian cancer.
    Markowska J
    Eur J Gynaecol Oncol; 2003; 24(1):7-11. PubMed ID: 12691308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Monoclonal anti-idiotype antibodies in immunotherapy of ovarian carcinoma (MAb ACA125) and breast carcinoma (MAb ACA14C5)].
    Wagner U; Köhler S; Prietl G; Giffels P; Schmidt-Nicolai S; Schlebusch H; Grünn U; Bender H; Biersack HJ; De Potter C; Krebs D; Wallwiener D
    Zentralbl Gynakol; 1999; 121(4):190-5. PubMed ID: 10355096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of monoclonal antibodies for the treatment of epithelial ovarian cancer (review).
    Oei AL; Sweep FC; Thomas CM; Boerman OC; Massuger LF
    Int J Oncol; 2008 Jun; 32(6):1145-57. PubMed ID: 18497976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune responses to murine monoclonal antibody-B43.13 correlate with prolonged survival of women with recurrent ovarian cancer.
    Möbus VJ; Baum RP; Bolle M; Kreienberg R; Noujaim AA; Schultes BC; Nicodemus CF
    Am J Obstet Gynecol; 2003 Jul; 189(1):28-36. PubMed ID: 12861134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy in a human ovarian cancer xenograft model with two bispecific monoclonal antibodies: OV-TL 3/CD3 and OC/TR.
    van Ravenswaay Claasen HH; Eggermont AM; Nooyen YA; Warnaar SO; Fieuren GJ
    Gynecol Oncol; 1994 Feb; 52(2):199-206. PubMed ID: 8314139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian carcinoma therapy with monoclonal antibodies.
    Canevari S; Miotti S; Bottero F; Valota O; Colnaghi MI
    Hybridoma; 1993 Oct; 12(5):501-7. PubMed ID: 8300122
    [No Abstract]   [Full Text] [Related]  

  • 7. Oregovomab: anti-CA-125 monoclonal antibody B43.13--AltaRex, B43.13, MAb B43.13, monoclonal antibody B43.13.
    Drugs R D; 2006; 7(6):379-83. PubMed ID: 17073521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical applications of monoclonal antibodies against ovarian cancer-associated antigens.
    Kenemans P; Yedema CA; Hilgers JH; Massuger LF; Verheijen RH; Thomas CM; Poels LG
    Eur J Obstet Gynecol Reprod Biol; 1988 Nov; 29(3):207-18. PubMed ID: 3065097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy in ovarian cancer.
    Krishnan V; Berek JS; Dorigo O
    Curr Probl Cancer; 2017; 41(1):48-63. PubMed ID: 28169004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies in the management of ovarian cancer. A clinical perspective.
    Rubin SC
    Cancer; 1993 Feb; 71(4 Suppl):1602-12. PubMed ID: 8431896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigen-specific active immunotherapy for ovarian cancer.
    Leffers N; Daemen T; Helfrich W; Boezen HM; Cohlen BJ; Melief CJ; Nijman HW
    Cochrane Database Syst Rev; 2014 Sep; (9):CD007287. PubMed ID: 25229990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic monoclonal antibodies: a little history, a lot of engineering, and... some clinical successes].
    Siberil S; Dutertre CA; Boix C; Teillaud JL
    Transfus Clin Biol; 2005 Jun; 12(2):114-22. PubMed ID: 15907389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activating anti-idiotypic human anti-mouse antibodies for immunotherapy of ovarian carcinoma.
    Baum RP; Niesen A; Hertel A; Nancy A; Hess H; Donnerstag B; Sykes TR; Sykes CJ; Suresh MR; Noujaim AA
    Cancer; 1994 Feb; 73(3 Suppl):1121-5. PubMed ID: 8306256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A monoclonal antiidiotypic antibody ACA 125 mimicking the tumor-associated antigen CA 125 for immunotherapy of ovarian cancer.
    Schlebusch H; Wagner U; Grünn U; Schultes B
    Hybridoma; 1995 Apr; 14(2):167-74. PubMed ID: 7590775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regression of advanced ovarian carcinoma by intraperitoneal treatment with autologous T lymphocytes retargeted by a bispecific monoclonal antibody.
    Canevari S; Stoter G; Arienti F; Bolis G; Colnaghi MI; Di Re EM; Eggermont AM; Goey SH; Gratama JW; Lamers CH
    J Natl Cancer Inst; 1995 Oct; 87(19):1463-9. PubMed ID: 7674333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy of human ovarian carcinoma with OvaRex MAb-B43.13 in a human-PBL-SCID/BG mouse model.
    Schultes BC; Zhang C; Xue LY; Noujaim AA; Madiyalakan R
    Hybridoma; 1999 Feb; 18(1):47-55. PubMed ID: 10211788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotherapy of ovarian cancer.
    Lidor Y; Bast RC
    Nat Immun Cell Growth Regul; 1988; 7(4):193-215. PubMed ID: 3070370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen-specific active immunotherapy for ovarian cancer.
    Leffers N; Daemen T; Helfrich W; Boezen HM; Cohlen BJ; Melief K; Nijman HW
    Cochrane Database Syst Rev; 2010 Jan; (1):CD007287. PubMed ID: 20091627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Target therapy of cancer: implementation of monoclonal antibodies and nanobodies.
    Majidi J; Barar J; Baradaran B; Abdolalizadeh J; Omidi Y
    Hum Antibodies; 2009; 18(3):81-100. PubMed ID: 19729803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antibodies against cancer].
    Barriuso Feijóo J; Sundlov A; González Barón M
    Rev Clin Esp; 2004 Dec; 204(12):649-54. PubMed ID: 15710074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.